Core Viewpoint - Lepu Medical's stock price closed at 17.27 yuan, reflecting a decline of 3.41% [1] Group 1: Stock Performance - Lepu Medical's stock reached an annual high of 21.18 yuan on August 25 [2] - The stock has experienced a notable decrease since its peak [1] Group 2: Analyst Ratings - China Galaxy Securities maintained a "recommended" rating for Lepu Medical, highlighting innovation and consumer-driven growth as key factors for performance recovery [2] - China International Capital Corporation affirmed a "outperform" rating, noting a stabilization in performance and anticipation of new growth drivers [2] - Huatai Securities retained a "buy" rating, emphasizing accelerated performance growth in Q2 and a rich outlook for long-term business prospects [2]
乐普医疗跌3.41% 中国银河等3券商年内高点唱多